BMT-124110
BMT-124110 is a potent, selective AAK1 inhibitor with an IC50 of 0.9 nM. BMT-124110 shows antinociceptive activity. BMT-090605 inhibits BMP-2-inducible protein kinase (BIKE) and Cyclin G-associated kinase (GAK) with IC50s of 17 and 99 nM, respectively[1].
Product Specifications
CAS Number
[1679371-59-5]
UNSPSC
12352005
Target
AAK1
Type
Reference compound
Related Pathways
Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/bmt-124110.html
Purity
99.15
Solubility
10 mM in DMSO
Smiles
CC(NC1=CC2=C(COC3=CC(OC[C@@](C)(N)CC(C)C)=CC=C32)C=N1)=O
Molecular Formula
C21H27N3O3
Molecular Weight
369.46
References & Citations
[1]Kostich W, et al. Inhibition of AAK1 Kinase as a Novel Therapeutic Approach to Treat Neuropathic Pain. J Pharmacol Exp Ther. 2016 Sep;358 (3) :371-86.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
057309-01 10 µg
Tumor Necrosis Factor Alpha Induced Protein 3 (TNFaIP3), Recombinant, Human, His-Tag
Ask
View Details 
057309-02 50 µg
Tumor Necrosis Factor Alpha Induced Protein 3 (TNFaIP3), Recombinant, Human, His-Tag
Ask
View Details 057309-03 100 µg
Tumor Necrosis Factor Alpha Induced Protein 3 (TNFaIP3), Recombinant, Human, His-Tag
Ask
View Details 057309-04 200 µg
Tumor Necrosis Factor Alpha Induced Protein 3 (TNFaIP3), Recombinant, Human, His-Tag
Ask
View Details 
MBS7041531-01 0.02 mg
Recombinant Yersinia pseudotuberculosis serotype O:1b UPF0299 membrane protein YpsIP31758_2460 (YpsIP31758_2460)
Ask
View Details 
MBS7041531-02 0.1 mg
Recombinant Yersinia pseudotuberculosis serotype O:1b UPF0299 membrane protein YpsIP31758_2460 (YpsIP31758_2460)
Ask
View Details